<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39431225</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2717-011X</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>05</Day></PubDate></JournalIssue><Title>Current journal of neurology</Title><ISOAbbreviation>Curr J Neurol</ISOAbbreviation></Journal><ArticleTitle>Anticoagulation in the management of septic cavernous sinus thrombosis secondary to rhino-orbito-cerebral mucormycosis: A retrospective real-world experience.</ArticleTitle><Pagination><StartPage>44</StartPage><EndPage>58</EndPage><MedlinePgn>44-58</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18502/cjn.v23i1.16432</ELocationID><Abstract><AbstractText><b>Background:</b> COVID-19 was associated with an increased number of patients with mucormycosis (MCR), followed by septic cavernous sinus thrombosis (SCST). We evaluated the association between anticoagulation (AC) and mortality/morbidity of COVID-19-associated MCR (CAM)-induced SCST. <b>Methods:</b> In this retrospective study, neurological sequelae, functional outcomes, and in-hospital mortality were compared between AC receivers and non-receivers. In addition, the association between AC and survivability was examined. <b>Results:</b> Twenty-nine patients (17 male; mean age: 51.27 years) with CAM-induced SCST were included in the study. The median intervals between COVID-19 and MCR, and COVID-19 and SCST were 19 and 27 days, respectively. Among AC recipients, the interval between SCST and AC initiation was 18 days, with an AC duration of 37 days. Baseline and management-related characteristics were comparable between AC recipients and non-recipients (P &gt; 0.050). AC receivers (n = 15) and non-receivers (n = 14) did not significantly differ in terms of the proportion of sequelae (6/15 vs. 5/14; P = 1.000), complete recovery (2/15 vs. 4/14; P = 0.687), and in-hospital mortality (3/15 vs. 3/14; P &gt; 0.999). Nevertheless, AC recipients had a longer hospital stay (72.0 vs. 35.5; P = 0.016). AC-related characteristics (AC receiving, type, early initiation, and duration) were not significantly different between survivors and non-survivors, or between recovered and disabled patients. <b>Conclusion:</b> In our study, CAM-induced SCST in-hospital mortality/morbidity did not differ between AC receivers and non-receivers. AC characteristics were not different between survivors and non-survivors, or recovered and disabled patients. However, the small sample size may have limited the ability to detect significant differences, leading to inconclusive results.</AbstractText><CopyrightInformation>Copyright © 2024 Iranian Neurological Association, and Tehran University of Medical Sciences Published by Tehran University of Medical Sciences.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amani</LastName><ForeName>Kiana</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Neurology Ward, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahbazi</LastName><ForeName>Mojtaba</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Iranian Center of Neurological Research, Neuroscience Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behkar</LastName><ForeName>Atefeh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farahmand</LastName><ForeName>Ghasem</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neurology Ward, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghafouri</LastName><ForeName>Shima</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neurology Ward, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heydari</LastName><ForeName>Sanaz</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neurology Ward, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaeedi</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurology Ward, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magrouni</LastName><ForeName>Hana</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Neurology Ward, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alizadeh</LastName><ForeName>Fatemeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neurology Ward, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghabaee</LastName><ForeName>Mojdeh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Iranian Center of Neurological Research, Neuroscience Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarraf</LastName><ForeName>Payam</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Iranian Center of Neurological Research, Neuroscience Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tafakhori</LastName><ForeName>Abbas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Iranian Center of Neurological Research, Neuroscience Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amirifard</LastName><ForeName>Hamed</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Iranian Center of Neurological Research, Neuroscience Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranji-Burachaloo</LastName><ForeName>Sakineh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Iranian Center of Neurological Research, Neuroscience Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammadianinejad</LastName><ForeName>Seyed Ehsan</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Iranian Center of Neurological Research, Neuroscience Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jameie</LastName><ForeName>Melika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Iranian Center of Neurological Research, Neuroscience Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harirchian</LastName><ForeName>Mohammad Hossein</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Iranian Center of Neurological Research, Neuroscience Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Iran</Country><MedlineTA>Curr J Neurol</MedlineTA><NlmUniqueID>101769679</NlmUniqueID><ISSNLinking>2717-011X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anticoagulants</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cavernous Sinus Thrombosis</Keyword><Keyword MajorTopicYN="N">Mucormycosis</Keyword><Keyword MajorTopicYN="N">Septic</Keyword><Keyword MajorTopicYN="N">Treatment Outcome</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest in this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>16</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39431225</ArticleId><ArticleId IdType="pmc">PMC11489632</ArticleId><ArticleId IdType="doi">10.18502/cjn.v23i1.16432</ArticleId><ArticleId IdType="pii">CJN-23-44</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Caranfa JT, Yoon MK. Septic cavernous sinus thrombosis: A review. Surv Ophthalmol. 2021;66(6):1021–30.</Citation><ArticleIdList><ArticleId IdType="pubmed">33831391</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojan S, Al-Jumah M. Infection related cerebral venous thrombosis. J Pak Med Assoc. 2006;56(11):494–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">17183974</ArticleId></ArticleIdList></Reference><Reference><Citation>Southwick F. Septic Dural Sinus Thrombosis [Online]  [cited 2020 Nov 20].  Available from: URL: https://www.uptodate.com/contents/septic-cavernous-sinus-thrombosis.</Citation></Reference><Reference><Citation>Jacob MS, Gunasekaran K, Miraclin AT, Sadiq M, Kumar CV, Oommen A, et al. Clinical profile and outcome of patients with cerebral venous thrombosis secondary to bacterial infections. Ann Indian Acad Neurol. 2020;23(4):477–81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7657302</ArticleId><ArticleId IdType="pubmed">33223663</ArticleId></ArticleIdList></Reference><Reference><Citation>Weerasinghe D, Lueck CJ. Septic cavernous sinus thrombosis: Case report and review of the literature. Neuroophthalmology. 2016;40(6):263–76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5120738</ArticleId><ArticleId IdType="pubmed">27928417</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO COVID-19 dashboard [Online]  [cited 2022 Feb 28].  Available from: URL: https://data.who.int.</Citation></Reference><Reference><Citation>Zali A, Khodadoost M, Gholamzadeh S, Janbazi S, Piri H, Taraghikhah N, et al. Mortality among hospitalized COVID-19 patients during surges of SARS-CoV-2 alpha (B.1.1.7) and delta (B.1.617.2) variants. Sci Rep. 2022;12(1):18918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9640720</ArticleId><ArticleId IdType="pubmed">36344540</ArticleId></ArticleIdList></Reference><Reference><Citation>Jameie M, Safarian NM, Mansouri P, Jalali A, Aghajani F, Lotfi-Tokaldany M, et al. The impact of the COVID-19 pandemic on hospitalization rates due to prosthetic valve thrombosis. J Tehran Heart Cent. 2023;18(2):136–41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10459344</ArticleId><ArticleId IdType="pubmed">37637285</ArticleId></ArticleIdList></Reference><Reference><Citation>Soheili A, Khani S, Montazeri S, Shayegh A, Haji Miragha M, Jameie MS, et al. COVID-19 and acute kidney injury presentation; stages and prognosis. J Prev Epidemiol. 2021;6(1):e15.</Citation></Reference><Reference><Citation>Majidi F, Mohagheghi Dare Ranj A, Jameie M, Jameie M, Mansouri P, Varpaei HA, et al. The relationship between cardiological parameters and PCR in patients with coronavirus infection: A cross-sectional study. Medicine (Baltimore) 2022;101(50):e31935.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9771227</ArticleId><ArticleId IdType="pubmed">36550863</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Tee M, Roy AE, Fardin MA, Srichokchatchawan W, Habib HA, et al. The impact of COVID-19 pandemic on physical and mental health of Asians: A study of seven middle-income countries in Asia. PLoS One. 2021;16(2):e0246824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877638</ArticleId><ArticleId IdType="pubmed">33571297</ArticleId></ArticleIdList></Reference><Reference><Citation>Duden GS, Reiter J, Paswerg A, Weibelzahl S. Mental health of healthcare professionals during the ongoing COVID-19 pandemic: A comparative investigation from the first and second pandemic years. BMJ Open. 2023;13(3):e067244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10039975</ArticleId><ArticleId IdType="pubmed">36948559</ArticleId></ArticleIdList></Reference><Reference><Citation>Borhany H, Golbabaei S, Jameie M, Borhani K. Moral decision-making in healthcare and medical professions during the COVID-19 pandemic. Trends in Psychol. 2023;31(1):210–30.</Citation></Reference><Reference><Citation>Rafati A, Pasebani Y, Jameie M, Yang Y, Jameie M, Ilkhani S, et al. Association of SARS-CoV-2 vaccination or infection with bell palsy: A systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2023;149(6):493–504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10141297</ArticleId><ArticleId IdType="pubmed">37103913</ArticleId></ArticleIdList></Reference><Reference><Citation>Harirchian MH, Ghabaee M, Sarraf P, Ranji-Burachaloo S, Agah E, Mousavi SV, et al. Nervous system involvement in hospitalized patients with COVID-19: Clinical and laboratory associations with poorer outcomes. Infect Dis Clin Pract. 2023;32(1):e1332.</Citation></Reference><Reference><Citation>Jameie M, Togha M, Azizmohammad LM, Jafari E, Yazdan PM, Hemmati N, et al. Characteristics of headaches attributed to SARS-CoV-2 vaccination and factors associated with its frequency and prolongation: A cross-sectional cohort study. Front Neurol. 2023;14:1214501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10433229</ArticleId><ArticleId IdType="pubmed">37602254</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a viral land: A tale of two pathogens. Indian J Ophthalmol. 2021;69(2):244–52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7933891</ArticleId><ArticleId IdType="pubmed">33463566</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S, Gokhale T, Choudhury SS, Deb AK. COVID-19 and orbital mucormycosis. Indian J Ophthalmol. 2021;69(4):1002–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8012924</ArticleId><ArticleId IdType="pubmed">33727483</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19. Cureus. 2020;12(9):e10726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7599039</ArticleId><ArticleId IdType="pubmed">33145132</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi S, Telang R, Tambe M, Havaldar R, Sane M, Shaikh A, et al. Outbreak of mucormycosis in coronavirus disease patients, Pune, India. Emerg Infect Dis. 2022;28(1):1–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8714213</ArticleId><ArticleId IdType="pubmed">34586055</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg S, Masheshwari D, Bhushan B, Sardana V, Jain RK. Covid-19 and mucormycosis superinfection: prospective, obsevational study in a single center. Ann Indian Acad Neurol. 2022;25(3):441–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9350760</ArticleId><ArticleId IdType="pubmed">35936631</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahalaxmi I, Jayaramayya K, Venkatesan D, Subramaniam MD, Renu K, Vijayakumar P, et al. Mucormycosis: An opportunistic pathogen during COVID-19. Environ Res. 2021;201:111643.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8258024</ArticleId><ArticleId IdType="pubmed">34237335</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha ICN, Hasan MM, Goyal S, Patel T, Jain S, Ghosh A, et al. COVID-19 and mucormycosis syndemic: Double health threat to a collapsing healthcare system in India. Trop Med Int Health. 2021;26(9):1016–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447294</ArticleId><ArticleId IdType="pubmed">34117677</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021;15(4):102146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8137376</ArticleId><ArticleId IdType="pubmed">34192610</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen M, Honavar SG, Bansal R, Sengupta S, Rao R, Kim U, et al. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol. 2021;69(7):1670–92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8374756</ArticleId><ArticleId IdType="pubmed">34156034</ArticleId></ArticleIdList></Reference><Reference><Citation>Avatef FM, Rezaei L, Javadirad E, Iranfar K, Khosravi A, Amini SJ, et al. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study. Mycoses. 2021;64(11):1366–77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447086</ArticleId><ArticleId IdType="pubmed">34252988</ArticleId></ArticleIdList></Reference><Reference><Citation>Pakdel F, Ahmadikia K, Salehi M, Tabari A, Jafari R, Mehrparvar G, et al. Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran. Mycoses. 2021;64(10):1238–52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242414</ArticleId><ArticleId IdType="pubmed">34096653</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni R, Pujari S. COVID-19-associated mucormycosis: What neurologists should know? Ann Indian Acad Neurol. 2022;25(3):330–1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9350789</ArticleId><ArticleId IdType="pubmed">35936635</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox GM. Mucormycosis (zygomycosis) [Online]  [cited 2023 Jan 22].  Available from: URL: https://www.uptodate.com/contents/mucormycosis-zygomycosis?search=Mucormycosis%20(zygomycosis)&amp;amp;source=search_result&amp;amp;selectedTitle=1~70&amp;amp;usage_type=default&amp;amp;display_rank=1.</Citation></Reference><Reference><Citation>Khacha A, Bouchal S, Ettabyaoui A, Haloua M, Lamrani YA, Boubbou M, et al. Cavernous sinus thrombosis in a COVID-19 patient: A case report. Radiol Case Rep. 2021;16(3):480–2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7723769</ArticleId><ArticleId IdType="pubmed">33318774</ArticleId></ArticleIdList></Reference><Reference><Citation>Padma Srivastava MV, Vishnu VY, Pandit AK. Mucormycosis epidemic and stroke in India during the COVID-19 pandemic. Stroke. 2021;52(10):e622–e623.</Citation><ArticleIdList><ArticleId IdType="pubmed">34525840</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehara HR, Puri I, Singhal V, Ih S, Bishnoi BR, Sirohi P. Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: Case series from the north-western part of India. Indian J Med Microbiol. 2021;39(3):380–3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8153224</ArticleId><ArticleId IdType="pubmed">34052046</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubey S, Mukherjee D, Sarkar P, Mukhopadhyay P, Barman D, Bandopadhyay M, et al. COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum. Diabetes Metab Syndr. 2021;15(5):102267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8407938</ArticleId><ArticleId IdType="pubmed">34509790</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatia K, Jones NS. Septic cavernous sinus thrombosis secondary to sinusitis: are anticoagulants indicated? A review of the literature. J Laryngol Otol. 2002;116(9):667–76.</Citation><ArticleIdList><ArticleId IdType="pubmed">12437798</ArticleId></ArticleIdList></Reference><Reference><Citation>Desa V, Green R. Cavernous sinus thrombosis: Current therapy. J Oral Maxillofac Surg. 2012;70(9):2085–91.</Citation><ArticleIdList><ArticleId IdType="pubmed">22326173</ArticleId></ArticleIdList></Reference><Reference><Citation>Southwick FS, Richardson EP, Swartz MN. Septic thrombosis of the dural venous sinuses. Medicine (Baltimore) 1986;65(2):82–106.</Citation><ArticleIdList><ArticleId IdType="pubmed">3512953</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirkey WP. Thrombosis of the cavernous sinus. Arch Otolaryngol (1925) 1950;51(6):917–24.</Citation><ArticleIdList><ArticleId IdType="pubmed">15419951</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikhi F, Yousefian N, Tehranipoor P, Kowsari Z. Estimation of the basic reproduction number of Alpha and Delta variants of COVID-19 pandemic in Iran. PLoS One. 2022;17(5):e0265489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9113584</ArticleId><ArticleId IdType="pubmed">35580114</ArticleId></ArticleIdList></Reference><Reference><Citation>World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4.</Citation><ArticleIdList><ArticleId IdType="pubmed">24141714</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu IT, Tse SL. Workshop 3--source of bias in case series, patient cohorts, and randomised controlled trials. Hong Kong Med J. 2011;17(6):478–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22147318</ArticleId></ArticleIdList></Reference><Reference><Citation>Caliendo AM, Hanson KE. COVID-19: Diagnosis [Online]  [cited 2023 Feb 6].  Available from: URL: https://www.uptodate.com/contents/covid-19-diagnosis.</Citation></Reference><Reference><Citation>Chakravarty J, Gupta MK, Tilak R, Kumar R, Maurya RP, Kumar N, et al. COVID-19-associated Mucormycosis: A clinico-epidemiological study. J Diabetes Complications. 2022;36(9):108284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9374498</ArticleId><ArticleId IdType="pubmed">35987108</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn TJ, Dawson J, Walters MR, Lees KR. Functional outcome measures in contemporary stroke trials. Int J Stroke. 2009;4(3):200–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">19659822</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine SR, Twyman RE, Gilman S. The role of anticoagulation in cavernous sinus thrombosis. Neurology. 1988;38(4):517–22.</Citation><ArticleIdList><ArticleId IdType="pubmed">3281056</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health. Clinical Spectrum of SARS-CoV-2 Infection [Online]  [cited 2022 Jun 6].  Available from: URL: https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/</Citation></Reference><Reference><Citation>Munjal M, Khurana AS. Fungal infections and cavernous sinus thrombosis. Indian J Otolaryngol Head Neck Surg. 2004;56(3):235–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3451890</ArticleId><ArticleId IdType="pubmed">23120086</ArticleId></ArticleIdList></Reference><Reference><Citation>Li DM, Shang PP, Zhu L, De Hoog GS. Rhino-orbital-cerebral mycosis and cavernous thrombosis. Eur J Inflamm. 2014;12(1):1–10.</Citation></Reference><Reference><Citation>Gelston CD, Durairaj VD, Simoes EA. Rhino-orbital mucormycosis causing cavernous sinus and internal carotid thrombosis treated with posaconazole. Arch Ophthalmol. 2007;125(6):848–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17563004</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni R, Misra UK, Meshram C, Kochar D, Modi M, Vishnu VY, et al. Epidemic of mucormycosis in COVID-19 pandemic: A position paper. Ann Indian Acad Neurol. 2022;25(1):7–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8954338</ArticleId><ArticleId IdType="pubmed">35342268</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav S, Bs N, Ak S. Clinical profile of central nervous system involvement in patients with rhino orbital cerebral mucormycosis. J Assoc Physicians India. 2022;70(4):11–2.</Citation><ArticleIdList><ArticleId IdType="pubmed">35443423</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Poel NA, Mourits MP, de Win MML, Coutinho JM, Dikkers FG. Prognosis of septic cavernous sinus thrombosis remarkably improved: A case series of 12 patients and literature review. Eur Arch Otorhinolaryngol. 2018;275(9):2387–95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6096574</ArticleId><ArticleId IdType="pubmed">29998385</ArticleId></ArticleIdList></Reference><Reference><Citation>Paybast S, Mohamadian R, Emami A, Jameie M, Shahrab F, Zamani F, et al. Safety and efficacy of endovascular thrombolysis in patients with acute cerebral venous sinus thrombosis: A systematic review. Interv Neuroradiol. 2022:15910199221143418. [Online ahead of print]</Citation><ArticleIdList><ArticleId IdType="pubmed">36471504</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YH, Chen PY, Ting PJ, Huang FL. A review of eight cases of cavernous sinus thrombosis secondary to sphenoid sinusitis, including a12-year-old girl at the present department. Infect Dis (Lond) 2017;49(9):641–6.</Citation><ArticleIdList><ArticleId IdType="pubmed">28535728</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebelo J, Nayan S, Choong K, Fulford M, Chan A, Sommer DD. To anticoagulate? Controversy in the management of thrombotic complications of head &amp; neck infections. Int J Pediatr Otorhinolaryngol. 2016;88:129–35.</Citation><ArticleIdList><ArticleId IdType="pubmed">27497400</ArticleId></ArticleIdList></Reference><Reference><Citation>Funamura JL, Nguyen AT, Diaz RC. Otogenic lateral sinus thrombosis: Case series and controversies. Int J Pediatr Otorhinolaryngol. 2014;78(5):866–70.</Citation><ArticleIdList><ArticleId IdType="pubmed">24680135</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah UK, Jubelirer TF, Fish JD, Elden LM. A caution regarding the use of low-molecular weight heparin in pediatric otogenic lateral sinus thrombosis. Int J Pediatr Otorhinolaryngol. 2007;71(2):347–51.</Citation><ArticleIdList><ArticleId IdType="pubmed">17126414</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>